RXi Pharmaceuticals Corp. (RXII) Posts Q1 Loss of 32c/Share
Tweet
Share
E-mailGet Alerts RXII Hot Sheet
Join SI Premium – FREE
RXi Pharmaceuticals Corp. (NASDAQ: RXII) reported Q1 EPS of ($0.32), $0.01 worse than the analyst estimate of ($0.31).
For earnings history and earnings-related data on RXi Pharmaceuticals Corp. (RXII) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Piper Sandler on Virtu Financial (VIRT): 'The most overlooked name in our coverage'
- Integra LifeSciences cuts 2026 outlook after Cincinnati flood
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
